News
-
-
-
-
PRESS RELEASE
Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024
Abivax presents four abstracts on obefazimod for ulcerative colitis and colon cancer model at Digestive Disease Week 2024. The company highlights novel mechanism of action and positive clinical data for obefazimod -
PRESS RELEASE
Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024
Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024. The event will showcase new data on obefazimod's impact and mechanism of action -
-
PRESS RELEASE
Media Release: Sensirion product announcement: miniature liquid flow sensor platform for subcutaneous drug delivery
Sensirion announces the SLD3x series, a miniature liquid flow sensor platform for subcutaneous drug delivery. Enhancing patient safety and dosing precision in various therapies -
PRESS RELEASE
Press release: Deutsche Beteiligungs AG: Strong portfolio activity – continued progress in DBAG’s development
Deutsche Beteiligungs AG reports strong portfolio activity and continued progress in development with a six percent increase in net asset value to 673.1 million euros. Forecast confirmed -
-